PGRMC1 and neoplasm: A possibility exists in that the newly discovered progesterone receptor membrane component 1 (PGRMC1) [54,55] or the family of membrane PRs (mPRα, β, γ, δ, ε) [55-57] mediate the anti-tumor effects of MF.